Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the effectiveness of rifaximin versus norfloxacin for
secondary prevention of spontaneous bacterial peritonitis in patients with liver cirrhosis
and ascites.